Document is current
Any future updates will be listed below
-
Authors
Dziodzio, Tomasz https://orcid.org/0000-0002-3337-4573
Öllinger, Robert
Schöning, Wenzel
Rothkäppel, Antonia
Nikolov, Radoslav
Juraszek, Andrzej
Ritschl, Paul V.
Stockmann, Martin
Pratschke, Johann
Jara, Maximilian
-
Funding
Funding for this research was provided by:
FP7 Ideas: European Research Council (287596)
- License Information
-
More Information
Article History
Received: 18 July 2019
Accepted: 29 July 2020
First Online: 12 August 2020
Change Date: 8 December 2020
Change Type: Update
Change Details: Open Access Funding note was added to backmatter text of the article. This article has been updated to correct this.
Ethics approval and consent to participate
: Written informed consent was obtained from all participants of the study. The study was approved by the Charité institutional Ethics Committee and registered at the German Clinical Trials Register prior to study start (DRKS-ID: DRKS00005308).
: Not applicable.
: Martin Stockmann is the inventor of the LiMAx test and has capital interest in Humedics, the company marketing the LiMAx test. Maximillian Jara discloses receiving research grants in the frame of the d-LIVER European Commission Framework Program. Tomasz Dziodzio and the remaining authors, who have taken part in this study, declared they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
